phytic acid has been researched along with Prosthesis Durability in 1 studies
Phytic Acid: Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.
myo-inositol hexakisphosphate : A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Torrecilla, C | 1 |
Fernández-Concha, J | 1 |
Cansino, JR | 1 |
Mainez, JA | 1 |
Amón, JH | 1 |
Costas, S | 1 |
Angerri, O | 1 |
Emiliani, E | 1 |
Arrabal Martín, MA | 1 |
Arrabal Polo, MA | 1 |
García, A | 1 |
Reina, MC | 1 |
Sánchez, JF | 1 |
Budía, A | 1 |
Pérez-Fentes, D | 1 |
Grases, F | 1 |
Costa-Bauzá, A | 1 |
Cuñé, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Multicenter, Controlled and Randomized Clinical Trial to Evaluate the Combined Use of a Medical Device and a Food Supplement in the Control of Urinary pH in Patients With an Implanted Double Pigtail Stent[NCT03343275] | 105 participants (Actual) | Interventional | 2017-12-13 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for phytic acid and Prosthesis Durability
Article | Year |
---|---|
Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial.
Topics: Administration, Oral; Adult; Calcinosis; Crystallization; Double-Blind Method; Female; Humans; Hydro | 2020 |